Skip to content

Effect of endotracheal tube on ventilator associated pneumonia in Intensive Care Unit patients

Effect of EVAC endotracheal tube on decreasing ventilator associated pneumonia in critically ill patients admitted to Intensive Care Units

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000038998
Enrollment
90
Registered
2011-01-12
Start date
2011-02-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Almost 10-28% of patients admitted to intensive Care Units(ICU) suffered from Ventilator Associated Pneumonia(VAP) which leads to increasing mortality,ICU length of stay and mortality. As micro or macroaspiration of subglottic secretions is one of the most important risk factors for developing VAP, adevice that can suction these secretion may help to decreasing VAP. So in this study we want to evaluate the efficacy of EVAC endotracheal tube in decreasing VAP in critical ill patients. ninty patients will be enrolled in this study. patient will be allocated to two 45 patient groups. One group will be intubated with EVAC endotracheal tube and the other group will be intubated with standard tube. the Vap rate, mortality, ICU length of stay and duration of mechanical ventilation will be noted for each patient.

Interventions

Intubation of patients with EVAC oral endotracheal tube.(A specific tube with a distal lumen for suctioning of subglottic secretions and very thin cuff with poly urethane material which has not any folds on it after cuff filling). Patients will be intubated minimum 3 days until they will meet extubation criteria.

Sponsors

Tabriz University of Medical Sciences
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Adult patients(more than 18 years old) who will be ventilated for more than 3 days

Exclusion criteria

previous history of mechanical ventilation,pregnancy, Human Immunodefficiency Virus infection, malignancy,Immunosuppressive therapy, leukocyte count less than 1000/mm3

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026